Claire Bombardier
Division of Clinical Decision Making and Health Care
Toronto General Research Institute
Toronto General Hospital
Toronto
Canada
Name/email consistency: high
- An evidence-based evaluation of the gastrointestinal safety of coxibs. Bombardier, C. Am. J. Cardiol. (2002)
- Minimal clinically important difference. Low back pain: outcome measures. Bombardier, C., Hayden, J., Beaton, D.E. J. Rheumatol. (2001)
- Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M.B., Hawkey, C.J., Hochberg, M.C., Kvien, T.K., Schnitzer, T.J. N. Engl. J. Med. (2000)
- Outcome assessments in the evaluation of treatment of spinal disorders. Introduction. Bombardier, C. Spine (2000)
The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.








